Authors:
Vandamme, AM
Houyez, F
Banhegyi, D
Clotet, B
De Schrijver, G
De Smet, KAL
Hall, WW
Harrigan, R
Hellmann, N
Hertogs, K
Holtzer, C
Larder, B
Pillay, D
Race, E
Schmit, JC
Schuurman, R
Shulse, E
Sonnerborg, A
Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Horvath, A
Banhegyi, D
Biro, A
Ujhelyi, E
Veres, A
Horvath, L
Prohaszka, Z
Bacsi, A
Tarjan, V
Romics, L
Horvath, I
Toth, FD
Fust, G
Karadi, I
Citation: A. Horvath et al., High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART, IMMUNOBIOL, 203(5), 2001, pp. 756-768
Authors:
Prohaszka, Z
Daha, MR
Susal, C
Daniel, V
Szlavik, J
Banhegyi, D
Nagy, K
Varkonyi, V
Horvath, A
Ujhelyi, E
Toth, FD
Uray, K
Hudecz, F
Fust, G
Citation: Z. Prohaszka et al., C1q autoantibodies in HIV infection: Correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins, CLIN IMMUNO, 90(2), 1999, pp. 247-255
Authors:
Szabo, J
Prohaszka, Z
Toth, FD
Gyuris, A
Segesdi, J
Banhegyi, D
Ujhelyi, E
Minarovits, J
Fust, G
Citation: J. Szabo et al., Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load, AIDS, 13(14), 1999, pp. 1841-1849